Search

everythinglearnresearchcommunity

for

Search:↓

Babies who gain weight quickly, especially in the first 3 months, may start puberty earlier.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

The analysis shows the U.S. leads in tissue expansion research, mainly for breast reconstruction, with a slightly higher complication rate when using acellular dermal matrix.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Reporter characteristics affect detection of hair loss from cancer therapy.

Pumpkin seeds may improve health due to their rich nutrients and potential to treat various conditions.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Oral minoxidil may help hair regrowth in female cancer survivors.

Robotic technology in plastic surgery shows promise but needs more research and cost reduction for wider use.

The conclusions are: fecal short-chain fatty acids may help prevent cancer, fiber intake can reduce obesity, weight loss is hard for obese people, low BMI cancer patients are more prone to chemotherapy side effects, intermittent fasting benefits gut health, cherry laurel has health benefits in rats, certain gene variations can increase stress in hair loss patients, fecal acids can affect blood sugar levels, cold agglutinin can affect blood test results in autoimmune patients, and people with Crohn's disease have higher levels of a certain chemical in their blood.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

The meeting highlighted the genetic basis of female pattern hair loss and various skin health insights.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Adding stem cells to fat grafts for facial rejuvenation might improve outcomes, but more research is needed to confirm safety and effectiveness.

Breast cancer alters specific molecular structures in hair, which revert after cancer removal.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Breast cancer patients need strong psychological support to improve their quality of life.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Tamoxifen caused hair loss in a 52-year-old woman.

Breast implants are linked to autoimmune symptoms, with over half of patients feeling better after removal, but the exact cause is unclear and may involve bacterial biofilm.

CK 5/6 expression in breast cancer is linked to negative hormone receptor status and higher tumor grade.